DIGITAL EDITION

ARCHIVES

Category: Departments

Quantitative Characterization of the Smoothness of Extended-release Methylphenidate Pharmacokinetic Profiles

by Michelle D. Po, PhD; Roberto Gomeni, PhD, HDR, FCP; and Bev Incledon, PhD Dr. Po is with Highland Therapeutics Inc. in Toronto, Ontario, Canada. Dr. Gomeni is with PharmacoMetrica

A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis

by Rachel Little, MA, and Dale D’Mello, MD Ms. Little is a science writer in Lansing, Michigan. Dr. D’Mello is Associate Professor Emeritus with the Department of Psychiatry at Michigan

Self-administration of Psilocybin in the Setting of Treatment-resistant Depression

by Ashley Lyons, MPA, PA-C Dr. Lyons is a Doctor of Medical Science in Psychiatry at Rocky Mountain University School of Health Professions in Norfolk, Virginia. Funding: No funding was

Noah Syndrome: A Review Regarding Animal Hoarding with Squalor

by Leonor Moreira Abreu, MD, MSc, and João Gama Marques, MD, MSc, PhD Dr. Moreira Abreu and Prof. Gama Marques are with Clínica Universitária de Psiquiatria e Psicologia Médica, Faculdade

EcoMeditation Modifies Brain Resting State Network Activity

by Peta Stapleton, PhD; Dawson Church, PhD; Oliver Baumann, PhD; and Debbie Sabot, BA, Grad Dip Psych Drs. Stapleton and Baumann and Ms. Sabot are with the School of Psychology,

Abnormality of Contingent Negative Variation Correlates with Parkinson’s Disease Severity

by Plamen Tzvetanov, MD, Phd, DSc, FRCP; Ivan Lisichkov, MD, PhD; Rossen T. Rousseff MD, PhD; Vishwajit Hegde, MD, FRCP; and Sergey Kostadinov, MD, PhD Prof. Tzvetanov is with the

Risk Management: On the Record: Documentation of Psychiatric Treatment

by Ann L. McNary, JD Ms. McNary is Senior Risk Manager at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: The

Letter to the Editor: Innovative Rehabilitation Technologies in the COVID-19 Era: Two Sides of the Same Coin

Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(4–6):8–9.

Letter to the Editor: Orthognathic Surgery for Patients with Neurodevelopmental Disorders Requires Careful Decision-making by a Multidisciplinary Team

Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2022;19(4–6):9–10.

Use of Repetitive Transcranial Magnetic Stimulation in Child Psychiatry

by Anca Maria Bejenaru, MD, and Narpinder Kaur Malhi, MD Drs. Bejenaru and Malhi are with the Department of Psychiatry and Behavioral Health, Christiana Care in Wilmington, Delaware. Funding: No

Gender-affirming Care for Transgender Patients

by Nita Bhatt MD, MPH; Jesse Cannella, MSIII; and Julie P. Gentile, MD, MBA Dr. Bhatt is Associate Director of Medical Student Education and Associate Professor in the Department of

Social Neuroscience and Mental Processes: How Does Our Brain Process Social Information?

by Gabriela Correia Teixeira, Graduating in Psychology; Ana Maria Mazon Araújo, Graduating in Psychology; and Michael Jackson Oliveira de Andrade, Doctor of Psychology All authors are with the Laboratory of

SIBAT—A Computerized Assessment Tool for Suicide Ideation and Behavior: Development and Psychometric Properties

by Larry Alphs, MD, PhD; Dong-Jing Fu, MD, PhD; David Williamson, PhD; Carol Jamieson, BSc, FIBMS; John Greist, MD; Magdalena Harrington, PhD; Jean-Pierre Lindenmayer, MD; Cheryl McCullumsmith, MD, PhD; David

Acute Thalamic Ischemic Stroke in an Older Patient Newly Vaccinated with COVID-19 Vaccine Based on Adenoviral Vectors

by Kelly Mesa-Gamarra, MD; Mario Pineda-Paternina, MD; Edgar Castillo, MD; Loida Camargo, MD, MSc; Alexander Pabón, MD; Jorge Herrera-Pino, MD, PhD; Nicole Caldichoury, MSc; Pascual A. Gargiulo, MD, PhD; Yuliana

Comparative Analysis of Treatment Outcomes in Patients with Neuromyelitis Optica Spectrum Disorder Treated with Rituximab, Azathioprine, and Mycophenolate Mofetil: A Systematic Review and Meta-analysis

by Christy Magdalena, MD, MRes; Audrey Clarissa, MD, MRes; and Nathania Sutandi, MD, MRes All authors are with Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Referral Hospital in Jakarta,

Implementing Digital Technologies in Clinical Trials: Lessons Learned

by Georgia Mitsi, PhD; Todd Grinnell, BA; Suzanne Giordano, PhD; Thomas Goodin, Phd; Shahin Sanjar, PhD; Elizabeth Marble, BS; and Andrei Pikalov, MD, PhD All authors are with Sunovion Pharmaceuticals

Correlation Between CD133+ Stem Cells and Clinical Improvement in Patients with Autism Spectrum Disorders Treated with Intrathecal Bone Marrow-derived Mononuclear Cells

by Laura Villarreal-Martinez, MD; Laura Elia MartÍnez-Garza, MD; Iram Pablo Rodriguez-Sanchez, MD; Neri Alvarez-Villalobos, MD; Fernando Guzman-Gallardo, MD; Sulia Pope-Salazar, MD; Cynthia Salinas-Silva, MD; Maria Guadalupe Cepeda-Cepeda, MD; Alejandra Garza-Bedolla,

Risk Management: Adjusting to Your New Normal

by Ann L. McNary, JD Ms. McNary is Senior Risk Manager at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: The